Literature DB >> 7099765

Hereditary pyropoikilocytosis and elliptocytosis: clinical, laboratory, and ultrastructural features in infants and children.

J T Prchal, R P Castleberry, R T Parmley, W M Crist, A Malluh.   

Abstract

Clinical, biochemical and ultrastructural assessment of five Black children from four unrelated kindreds, who had morphologic and laboratory features of hereditary pyropoikilocytosis (HP) is described. In two of the unrelated propositi, both with relatives having elliptocytosis, the apparent HP gradually evolved into elliptocytosis. The mode of inheritance appeared to be autosomal dominant in one family and autosomal recessive in the other. None of the three children from two separate families with true HP had a parent with HP or elliptocytosis. A sixth Black child, whose mother also had elliptocytosis, demonstrated typical elliptocytosis from birth and never demonstrated the HP phenotype. Sequential quantitation of heat induced red cell fragmentation using histogram analyses revealed unchanged findings in three patients with true HP but progressive amelioration in the two patients with HP phenotype who eventually developed elliptocytic morphology. Previously unreported lesions in both true and apparent HP patients included endovesicle formation and submembrane particles, which were detected by electron microscopy, an increase in Heinz body formation, and elevation of oxidized glutathione levels. Our study demonstrates shared abnormalities present both in some neonates with elliptocytosis and in neonates with HP, which preclude the diagnosis of HP in infancy and provide further evidence of the heterogeneity of the elliptocytosis syndrome.

Entities:  

Mesh:

Year:  1982        PMID: 7099765     DOI: 10.1203/00006450-198206000-00017

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  5 in total

1.  Novel exon 2 α spectrin mutation and intragenic crossover: three morphological phenotypes associated with four distinct α spectrin defects.

Authors:  Sabina Swierczek; Archana M Agarwal; Kubendran Naidoo; Felipe R Lorenzo; Jonathan Whisenant; Roberto H Nussenzveig; Neeraj Agarwal; Theresa L Coetzer; Josef T Prchal
Journal:  Haematologica       Date:  2013-09-27       Impact factor: 9.941

2.  A common type of the spectrin alpha I 46-50a-kD peptide abnormality in hereditary elliptocytosis and pyropoikilocytosis is associated with a mutation distant from the proteolytic cleavage site. Evidence for the functional importance of the triple helical model of spectrin.

Authors:  P G Gallagher; W T Tse; T Coetzer; M C Lecomte; M Garbarz; H S Zarkowsky; A Baruchel; S K Ballas; D Dhermy; J Palek
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

3.  A molecular defect of spectrin in a subset of patients with hereditary elliptocytosis. Alterations in the alpha-subunit domain involved in spectrin self-association.

Authors:  J Lawler; S C Liu; J Palek; J Prchal
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

4.  Modulation of erythrocyte membrane mechanical stability by 2,3-diphosphoglycerate in the neonatal poikilocytosis/elliptocytosis syndrome.

Authors:  W C Mentzer; T A Iarocci; N Mohandas; P A Lane; B Smith; J Lazerson; T Hays
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

5.  Novel Insights into Mercury Effects on Hemoglobin and Membrane Proteins in Human Erythrocytes.

Authors:  Marina Piscopo; Rosaria Notariale; Fabiana Tortora; Gennaro Lettieri; Giancarlo Palumbo; Caterina Manna
Journal:  Molecules       Date:  2020-07-19       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.